---
category: news
title: "ProMIS Neurosciences Announces Second Quarter 2021 Results"
excerpt: "ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS or the Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases,"
publishedDateTime: 2021-08-12T11:32:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-promis-neurosciences-announces-second-quarter-2021-results-/2021/08/12/9429505.htm"
webUrl: "https://www.tmcnet.com/usubmit/-promis-neurosciences-announces-second-quarter-2021-results-/2021/08/12/9429505.htm"
type: article
quality: 4
heat: 4
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "jak3ppmhDZ51Nn8c0+Ik6QkZGjYUCpu4gvSYJx56a//ZxwQScv4on2ffpIXNCdxnsv3t7YWkQ7Fo+eETYPczbj7GEuTCIQEaYT8SUqlNq3m9KdRcTMxiH2x3NN3S5W8ZTYakW4AoPw8ilhCjvJ524x4LWgfo6WN8mvESUeRGnuG7Hntp+QvWBKl8sx7T7Ajqj6Bj3HGb1Rv5wz6YDwNRvq45/GRrzuhFzOtbjivTbJ0iJyj0K2vsO7ZgIRjQTLYlC8VMUXNU9Eg6GdIQ6kcxOjiujDVbuabso3Gh8oXmSHE7gA2fzY71snKjFZwgvGc410jWiF/AbqHZoKZIHlRmyPmCjg+hO71gdj4CydXjOOE=;DQ1EjQklgoRDr6RkDzzyeg=="
---

